Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
Titel:
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
Auteur:
Leighl, Natasha B Hellmann, Matthew D Hui, Rina Carcereny, Enric Felip, Enriqueta Ahn, Myung-Ju Eder, Joseph Paul Balmanoukian, Ani S Aggarwal, Charu Horn, Leora Patnaik, Amita Gubens, Matthew Ramalingam, Suresh S Lubiniecki, Gregory M Zhang, Jin Piperdi, Bilal Garon, Edward B